SCHEMBL23559563

SCHEMBL23559563

CC(C)(OC(=O)c1cccc(I)c1)C(F)(F)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53BP1 Q12888 1/20 0.39
▸ SLC7A5 Q01650 1/20 0.39
▸ MTOR P42345 2/20 0.36
▸ HDAC1 Q13547 1/20 0.35
▸ HDAC2 Q92769 1/20 0.35
▸ GRM5 P41594 1/20 0.35
▸ KAT6A Q92794 1/20 0.35
▸ MDM2 Q00987 1/20 0.35
▸ ACHE P22303 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ MAPT P10636 2/20 0.33
▸ F2 P00734 2/20 0.33
▸ TP53 P04637 1/20 0.33
▸ NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24360817 0.83 TSHR (0.49) ALDH1A1TSHRHSD17B10TDP1CYP1A2
SCHEMBL23559559 0.82 TPMT (0.41) ALDH1A1TSHRHSD17B10TDP1CYP1A2
SCHEMBL1417078 0.80 SLC7A5 (0.51) TP53BP1SLC7A5MTORHDAC1HDAC2
SCHEMBL30260183 0.80 SLC7A5 (0.51) TP53BP1SLC7A5MTORHDAC1HDAC2
SCHEMBL23559474 0.79 NOTUM (0.40) SLC7A5MTORALDH1A1HSD17B10
SCHEMBL23559318 0.78 PDK1 (0.36) ALDH1A1TSHRCYP1A2CYP2D6CYP2C19
SCHEMBL23559310 0.78 ESR1 (0.42) TDP1MAPT
SCHEMBL23559561 0.77 GABRG2 (0.32) —
SCHEMBL23559319 0.76 CA12 (0.36) MTORALDH1A1HSD17B10TDP1CYP1A2
SCHEMBL23559314 0.76 PTPN1 (0.34) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210188770-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2021-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210188770-A1 ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS SLC6A5, LIFR, SLC6A9 TP53BP1 4530/4885SLC7A5 122/4885MTOR 1304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback